American Gene Technologies logo

American Gene Technologies

AGT is developing and commercializing gene and cell therapy and targeting major diseases, including HIV/AIDS, Phenylketonuria (PKU) and Hepatocellular carcinoma.

4

Funding Rounds

$6.0m

Money raised

Overview

AGT is developing and commercializing gene and cell therapy and targeting major diseases, including HIV/AIDS, Phenylketonuria (PKU) and Hepatocellular carcinoma.

Funding series

Funding Series Analysis

The company American Gene Technologies has raised a total of $1.32m in funding over 4 rounds.

Key Insights:

  • American Gene Technologies seed round: $1.32m
  • American Gene Technologies Venture round, October 2014: $340k
  • American Gene Technologies International Inc. funding round, November 2015: $4.35m
American Gene Technologies logo
American Gene Technologies seed round $1.32m
American Gene Technologies logo
American Gene Technologies Venture round, October 2014 $340k
American Gene Technologies logo
American Gene Technologies International Inc. funding round, November 2015 $4.35m